Literature DB >> 1332222

Development of a simple indirect enzyme-linked immunosorbent assay for the detection of immunoglobulin M antibody in serum from patients following an outbreak of chikungunya virus infection in Yangon, Myanmar.

S Thein1, M La Linn, J Aaskov, M M Aung, M Aye, A Zaw, A Myint.   

Abstract

During 1984, 1548 children were admitted to the Yangon [Rangoon] Children's Hospital in Myanmar [Burma] with haemorrhagic fever. No evidence of recent dengue infection was found in 577 of the 803 children from whom paired sera were obtained, raising the possibility of reappearance of Chikungunya virus infection in Myanmar. An enzyme-linked immunosorbent assay (ELISA) for the detection of anti-Chikungunya virus immunoglobulin M (IgM) antibody was prepared and standardized using only reagents which are commercially available or which could be prepared without the use of sophisticated equipment. While there was 90% agreement between haemagglutination inhibition (HI) tests and the IgM ELISA in the diagnosis of acute Chikungunya virus infections, 12 additional patients with stationary anti-Chikungunya virus HI antibody titres could be identified as having acute Chikungunya infections using the ELISA. Furthermore, the ELISA could identify twice as many patients (31/103) at the time of admission to hospital as the HI test (15/103). There was no false positive IgM reaction with the ELISA which could be attributed to the presence of rheumatoid factor. Using the test, 103 of a sample of 163 children who presented to the Yangon Children's Hospital with fever/haemorrhagic fever were diagnosed as Chikungunya patients, 4 had possible dual Chikungunya and dengue infections, 16 had dengue, 30 had neither Chikungunya nor dengue infections, and a definitive diagnosis could not be made for 10 patients. Routine use of the ELISA would alert authorities to future outbreaks of Chikungunya virus infection and avoid admission to hospital of patients with a non-life-threatening viral disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332222     DOI: 10.1016/0035-9203(92)90260-j

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  11 in total

1.  Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.

Authors:  Rajpal Singh Kashyap; Shweta H Morey; Sonali S Ramteke; Nitin H Chandak; Manmohan Parida; Poonam S Deshpande; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

2.  Reemergence of Chikungunya virus in Indian Subcontinent.

Authors:  C V M Naresh Kumar; D V R Sai Gopal
Journal:  Indian J Virol       Date:  2010-09-03

3.  Retrospective seroepidemiological study of chikungunya infection in South Asia, Southeast Asia and the Pacific region.

Authors:  M M Ngwe Tun; S Inoue; K Z Thant; N Talemaitoga; A Aryati; E M Dimaano; R R Matias; C C Buerano; F F Natividad; W Abeyewickreme; N T T Thuy; L T Q Mai; F Hasebe; D Hayasaka; K Morita
Journal:  Epidemiol Infect       Date:  2016-03-28       Impact factor: 4.434

4.  Atypical chikungunya virus infections in immunocompromised patients.

Authors:  Adrian C L Kee; Samantha Yang; Paul Tambyah
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

5.  Detection of east/central/south African genotype of chikungunya virus in Myanmar, 2010.

Authors:  Mya Myat Ngwe Tun; Kyaw Zin Thant; Shingo Inoue; Takeshi Nabeshima; Kotaro Aoki; Aung Kyaw Kyaw; Tin Myint; Thi Tar; Kay Thwe Thwe Maung; Daisuke Hayasaka; Kouichi Morita
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

6.  Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.

Authors:  Byungki Cho; Bo-Young Jeon; Jungho Kim; Jaesang Noh; Jiha Kim; Minjung Park; Sun Park
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

7.  Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China.

Authors:  De Wu; Yonghui Zhang; Qiong Zhouhui; Jing Kou; Wenjia Liang; Huan Zhang; Corina Monagin; Qiaoli Zhang; Wenjie Li; Haojie Zhong; Jianfeng He; Hui Li; Songwu Cai; Changwen Ke; Jinyan Lin
Journal:  Virol J       Date:  2013-06-02       Impact factor: 4.099

8.  Chikungunya infection in children.

Authors:  Meghna R Sebastian; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2009-03-28       Impact factor: 5.319

9.  The study transplacental chikungunya virus antibody kinetics, Thailand.

Authors:  Veerachai Watanaveeradej; Timothy P Endy; Sriluck Simasathien; Angkool Kerdpanich; Napuschon Polprasert; Chanchai Aree; David W Vaughn; Ananda Nisalak
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

10.  Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006.

Authors:  Marcus Panning; Klaus Grywna; Marjan van Esbroeck; Petra Emmerich; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.